other material
confidence high
sentiment neutral
materiality 0.60
Co-Diagnostics removes $10M cap on ATM equity offering with Maxim Group
Co-Diagnostics, Inc.
- Amendment to equity distribution agreement removes fixed $10M aggregate limit on common stock sales.
- Future sales limited only by registered shares available under effective S-3 registration statement.
- Company extends standstill period with prior investors to August 14, 2026, restricting further equity issuances.
- Sales will be made through Maxim Group as agent under new prospectus supplement filed July 27, 2026.